Marc Vogel
Dados Biográficos
| ID | 7181618 |
|---|---|
| NOME | Marc Vogel |
| PRENOMES | Marc |
| SOBRENOME | Vogel |
| ASSINATURA | VOGEL M |
| AFILIAÇÕES | University of Basel |
| ORCID | 0000-0002-3088-0331 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 14 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 14 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2016 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2024 |
| ÍNDICE H | 0 |
Cannabis use and its association with psychopathological symptoms in a Swiss adult population
ADHD and depressive symptoms correlate with increased cannabis use in a cohort of regular users, suggesting potential self-medication in nonclinical populations. With the rising availability of cannabis worldwide, these results highlight the necessity for longitudinal studies to disentangle the complex dynamics between cannabis consumption and mental health symptoms
Effects of cannabis regulation in Switzerland
ClinicalTrials.gov (NCT05522205). https://clinicaltrials.gov/ct2/show/NCT05522205
Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry
SD are common among psychiatric patients receiving OAT and general psychiatric patients seeking psychotherapy. Professionals providing mental healthcare to patients must emphasize prevention and routine assessments of sexual functioning needs
Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice—Identifying Group Differences and Predictors
The high prevalence of SDs observed in MMT does not differ from the prevalence in HAT. Clinicians should actively inquire about their patients' sexual health in GP and OAT centers alike
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the Covid-19 pandemic–Is an update of legal restrictions warranted
Heroin-assisted treatment comprises the use of diacetylmorphine (pharmaceutical heroin) for individuals with severe opioid use disorder. In Switzerland, take-home doses in heroin-assisted treatment are more strictly regulated as compared to conventional opioid agonist treatment. In light of the COVID-19 pandemic, the Swiss Federal Council provisionally adapted its policy, allowing for longer prescriptions of take-home diacetylmorphine. Before the…
Chronic Pain among Individuals Experiencing Homelessness and Its Interdependence with Opioid and Other Substance Use and Mental Illness
Chronic pain and substance use disorders are serious conditions that are prevalent among homeless populations. The aim of this study was to examine the association between chronic pain and substance use among individuals experiencing homelessness and mental illness. We analyzed cross-sectional data from two sites of the At Home/Chez Soi study (Vancouver and Toronto) using bivariate statistics and multivariate logistic regression. Substance use an…
Opening the Doors of a Substance Use Disorder Ward—Benefits and Challenges From a Consumer Perspective
Open doors in psychiatry have been a subject of controversy in recent years. While some studies postulate the clinical necessity of closed doors, others challenge the theoretical advantages of this setting, mention numerous drawbacks of closed wards, and focus on the advantages of open-door settings. With regard to patients diagnosed with substance use disorders (SUD), other standards may apply. Very little research has been done on this topic. S…
Cannabis use in Switzerland 2015–2045
Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment
We present the case of a 35-year-old woman in heroin-assisted treatment (HAT) expressing the wish for the transition to oral opioid agonist treatment. After failed attempts to change to oral diacetylmorphine and slow-release oral morphine, respectively, she was induced on overlapping buprenorphine (BUP) treatment with the Bernese method. Gradual dose increases to BUP 48 mg per day did not result in attenuation of subjective effects of IV diacetyl…
Association of Substance Use Patterns with Psychiatric Disorders in Homeless Persons with Psychiatric Disorders in Vancouver
Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone
Rethinking retention in treatment of opioid dependence—The eye of the beholder
Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients
Methylphenidate (MPH) is commonly prescribed for attention deficit hyperactivity disorder (ADHD). Recreational nonmedical use has been described and also occurs in patients on opioid maintenance treatment (OMT). MPH has been proposed for use as replacement therapy in cocaine dependence, although evidence for efficacy is inconclusive. We conducted a cross-sectional interview study on patterns of MPH use in a sample of 20 MPH-using patients on OMT …
Fluchen und Schimpfen kontrastiv. Zur sexuellen, krankheitsbasierten, skatologischen und religiösen Fluch- und Schimpfwortprototypik im Niederländischen, Deutschen und Schwedischen
Sem obras proeminentes nesta página.
Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients
Methylphenidate (MPH) is commonly prescribed for attention deficit hyperactivity disorder (ADHD). Recreational nonmedical use has been described and also occurs in patients on opioid maintenance treatment (OMT). MPH has been proposed for use as replacement therapy in cocaine dependence, although evidence for efficacy is inconclusive. We conducted a cross-sectional interview study on patterns of MPH use in a sample of 20 MPH-using patients on OMT …
Rethinking retention in treatment of opioid dependence—The eye of the beholder
Association of Substance Use Patterns with Psychiatric Disorders in Homeless Persons with Psychiatric Disorders in Vancouver
Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone
Cannabis use in Switzerland 2015–2045
Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment
We present the case of a 35-year-old woman in heroin-assisted treatment (HAT) expressing the wish for the transition to oral opioid agonist treatment. After failed attempts to change to oral diacetylmorphine and slow-release oral morphine, respectively, she was induced on overlapping buprenorphine (BUP) treatment with the Bernese method. Gradual dose increases to BUP 48 mg per day did not result in attenuation of subjective effects of IV diacetyl…
Opening the Doors of a Substance Use Disorder Ward—Benefits and Challenges From a Consumer Perspective
Open doors in psychiatry have been a subject of controversy in recent years. While some studies postulate the clinical necessity of closed doors, others challenge the theoretical advantages of this setting, mention numerous drawbacks of closed wards, and focus on the advantages of open-door settings. With regard to patients diagnosed with substance use disorders (SUD), other standards may apply. Very little research has been done on this topic. S…
Chronic Pain among Individuals Experiencing Homelessness and Its Interdependence with Opioid and Other Substance Use and Mental Illness
Chronic pain and substance use disorders are serious conditions that are prevalent among homeless populations. The aim of this study was to examine the association between chronic pain and substance use among individuals experiencing homelessness and mental illness. We analyzed cross-sectional data from two sites of the At Home/Chez Soi study (Vancouver and Toronto) using bivariate statistics and multivariate logistic regression. Substance use an…
Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice—Identifying Group Differences and Predictors
The high prevalence of SDs observed in MMT does not differ from the prevalence in HAT. Clinicians should actively inquire about their patients' sexual health in GP and OAT centers alike
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the Covid-19 pandemic–Is an update of legal restrictions warranted
Heroin-assisted treatment comprises the use of diacetylmorphine (pharmaceutical heroin) for individuals with severe opioid use disorder. In Switzerland, take-home doses in heroin-assisted treatment are more strictly regulated as compared to conventional opioid agonist treatment. In light of the COVID-19 pandemic, the Swiss Federal Council provisionally adapted its policy, allowing for longer prescriptions of take-home diacetylmorphine. Before the…
Effects of cannabis regulation in Switzerland
ClinicalTrials.gov (NCT05522205). https://clinicaltrials.gov/ct2/show/NCT05522205
Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry
SD are common among psychiatric patients receiving OAT and general psychiatric patients seeking psychotherapy. Professionals providing mental healthcare to patients must emphasize prevention and routine assessments of sexual functioning needs
Fluchen und Schimpfen kontrastiv. Zur sexuellen, krankheitsbasierten, skatologischen und religiösen Fluch- und Schimpfwortprototypik im Niederländischen, Deutschen und Schwedischen
Cannabis use and its association with psychopathological symptoms in a Swiss adult population
ADHD and depressive symptoms correlate with increased cannabis use in a cohort of regular users, suggesting potential self-medication in nonclinical populations. With the rising availability of cannabis worldwide, these results highlight the necessity for longitudinal studies to disentangle the complex dynamics between cannabis consumption and mental health symptoms
Medicine (12 obras) · Psychiatry (10 obras) · Internal Medicine (8 obras) · Opioid (7 obras) · Psychology (7 obras) · Cannabis and Cannabinoid Research (5 obras) · Substance Abuse Treatment and Outcomes (5 obras) · Opioid Use Disorder Treatment (4 obras) · Population (4 obras) · Addiction (3 obras)